Wikidata

(Q63334527)

English

A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

clinical trial

In more languages

Statements

title
An Open-label, Randomized, Phase IIIb Trial Evaluating the Efficacy and Safety of Standard of Care +/- Continuous Bevacizumab Treatment Beyond Progression of Disease (PD) in Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) After First Line Treatment With Bevacizumab Plus a Platinum Doublet-containing Chemotherapy (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Argentina
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Denmark
0 references
France
0 references
Germany
0 references
Greece
0 references
Italy
0 references
Japan
0 references
Lebanon
0 references
Mexico
0 references
Netherlands
0 references
Oman
0 references
Slovakia
0 references
Spain
0 references
United Arab Emirates
0 references
start time
25 June 2011
0 references
end time
25 June 2016
0 references
number of participants
485
0 references
research intervention
bevacizumab
0 references
docetaxel
0 references
pemetrexed
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63334527&oldid=1857147988"